Capital International Ltd. CA Purchases 1,337 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Capital International Ltd. CA raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 63,356 shares of the medical equipment provider's stock after purchasing an additional 1,337 shares during the quarter. Intuitive Surgical accounts for about 1.3% of Capital International Ltd. CA's portfolio, making the stock its 18th biggest position. Capital International Ltd. CA's holdings in Intuitive Surgical were worth $33,069,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Atala Financial Inc bought a new stake in shares of Intuitive Surgical in the 4th quarter worth $25,000. Berbice Capital Management LLC purchased a new position in Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in Intuitive Surgical in the 4th quarter worth about $28,000. Hurley Capital LLC purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $28,000. Finally, Summit Securities Group LLC bought a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $30,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 over the last 90 days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Up 0.3 %

Shares of NASDAQ ISRG traded up $1.40 during mid-day trading on Friday, reaching $482.74. 1,618,989 shares of the company were exchanged, compared to its average volume of 1,589,481. Intuitive Surgical, Inc. has a 52 week low of $364.31 and a 52 week high of $616.00. The company's 50 day moving average price is $522.23 and its 200 day moving average price is $532.71. The stock has a market capitalization of $171.94 billion, a PE ratio of 75.31, a PEG ratio of 5.85 and a beta of 1.55.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. CICC Research initiated coverage on Intuitive Surgical in a report on Monday, January 27th. They set a "neutral" rating and a $550.00 price target on the stock. Barclays increased their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Piper Sandler reiterated an "overweight" rating and issued a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. UBS Group lifted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Finally, Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an "overweight" rating in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $611.81.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.